Hyaluronic acid pharmacokinetics study of ECM-E - Hyaluronic acid pharmacokinetics study of ECM-E

ADAPTGEN PHARMACEUTICAL CO.,LTD.0 个研究点目标入组 15 人开始时间: 2013年9月12日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•The subjects in conflict with any of the following condition are excluded. 1) A person who with the disease to gastrointestinal tract, liver, kidney, the heart which have an influence on absorption, distribution, metabolism, the excretion. 2) A person with a history of the surgery considerable in the gastrointestinal tract site, for example, gastrectomy, stomach and intestines suturation, intestinal tract resection and so on. 3) A person who has a food allergy in chicken and a chicken egg or a chronic food allergy. 4) A person who has Mucopolysaccharidosis. 5) Person with alcohol or drug dependence. 6) A person who has participated in other clinical study or received medical treatment of new drug within 3 months at the time of obtaining informed consent. 7) The person who took other drugs for less than one week to start this clinical trial. 8) A person who has taken the whole blood bleeds or apheresis(plasma apheresis and platelet apheresis) more than 200mL within 3 months at the time of obtaining informed consent or during the period between the time of obtaining informed consent and this clinical trial implementation. 9) A person who can not keep the compliance rules of participation in clinical trials and report symptoms. 10) In addition, the person who identified as improper by the principal investigator or subinvestigators.

发起方